Group items matching

in title, tags, annotations or url

Market Overview: Next-generation antibody therapeutics includes the use of new improvised therapeutic antibody to form innovative medicines for treating various diseases. Next-generation antibody therapeutics is developed clinically by pharmaceutical and biotechnology companies for several diseases. The Next Generation Antibody Therapeutics Market size was worth $ XX million in 2018 and is forecasted to reach $ XX million by 2026, expected to grow at a high CAGR during the forecast period 2019-2026. Market Dynamics: The Next Generation Antibody Therapeutics Market is growing due to several factors such as rising incidence of chronic diseases, increasing emergence of antibody technology, new drug discovery, large number of government initiatives, and growing research and development activities for new therapies. Rising prevalence of chronic disease such as cancer, asthma, diabetes and COPD are boosting the growth of the next generation antibody therapeutics market. For instance, according to National Cancer Institute in 2018, in United States, an estimated 1,735,350 new cases of cancer will be diagnosed and 609,640 people will die from the disease. The development of next-generation monoclonal antibodies has expanded beyond oncology into all therapeutic areas. For instance, ADCs were initially focused primarily on cancer, but Genentech has applied to infectious diseases, leading to the discovery and development of THIOMAB antibiotic conjugates (TACs) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). The technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, hence, driving the growth in the next-generation antibody therapeutics market. However, stringent government regulation, high cost and time required for research and development activities are some of the factors hindering the growth for global next-generation antibody therapeutics market. Market Segmentation: Based o

Clinical Trial Management Systems (CTMS) market research report segmented the global market on the basics of end-users, types, components, delivery mode and geography.

[No of Pages - 240] Browse data tables and figures/charts on Clinical Trial Management Systems (CTMS) market research report segmented the global market on the basics of end-users, types, components, delivery mode and geography.

Worksure delivers effective and successful training programs for Pre-clinical & Clinical scientific research, Medical Writing, Marketing and Sales personnel.

Optical Imaging Market (2013-2018) - Technology Trends And Applications Of Optical Coherence Tomography (OCT), Hyper Spectral Imaging (HSI), Near Infrared Spectroscopy (NIRS) And Photo- Acoustic Tomography (PAT) In Clinical Diagnostics, Clinical Research And Life Sciences With Market Landscape Analysis - Estimates Up To 2018

A social network for clinical researchers.

To bring new therapies to market, pharmaceutical, biotechnology, and medical device companies engage contract research organizations (CROs) for their expertise in navigating the complex landscape of product development and regulatory pathway.

[No of Slides - 147] Browse 10 tables and 36 figures/charts on Optical Imaging Market report covers the global market based on Technological aspects of Optical Coherence Tomography (OCT), Hyper Spectral Imaging (HSI), Photo Acoustic Tomography (PAT), Key Drivers & Geographic Regions covered.